- Home
- HOOK vs LNSR Comparison
HOOK vs LNSR Comparison
Compare HOOK & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOOK
- LNSR
- Stock Information
- Founded
- HOOK 2011
- LNSR 2004
- Country
- HOOK United States
- LNSR United States
- Employees
- HOOK N/A
- LNSR N/A
- Industry
- HOOK Biotechnology: Pharmaceutical Preparations
- LNSR Medical Electronics
- Sector
- HOOK Health Care
- LNSR Health Care
- Exchange
- HOOK Nasdaq
- LNSR Nasdaq
- Market Cap
- HOOK 61.8M
- LNSR 50.7M
- IPO Year
- HOOK 2019
- LNSR N/A
- Fundamental
- Price
- HOOK $4.74
- LNSR $4.53
- Analyst Decision
- HOOK Strong Buy
- LNSR
- Analyst Count
- HOOK 4
- LNSR 0
- Target Price
- HOOK $39.25
- LNSR N/A
- AVG Volume (30 Days)
- HOOK 22.2K
- LNSR 19.6K
- Earning Date
- HOOK 08-08-2024
- LNSR 08-08-2024
- Dividend Yield
- HOOK N/A
- LNSR N/A
- EPS Growth
- HOOK N/A
- LNSR N/A
- EPS
- HOOK N/A
- LNSR N/A
- Revenue
- HOOK $52,163,000.00
- LNSR $45,124,000.00
- Revenue This Year
- HOOK $165.17
- LNSR $22.89
- Revenue Next Year
- HOOK N/A
- LNSR $21.36
- P/E Ratio
- HOOK N/A
- LNSR N/A
- Revenue Growth
- HOOK 227.80
- LNSR 17.99
- 52 Week Low
- HOOK $4.10
- LNSR $1.80
- 52 Week High
- HOOK $11.30
- LNSR $5.60
- Technical
- Relative Strength Index (RSI)
- HOOK 38.95
- LNSR 49.72
- Support Level
- HOOK $5.08
- LNSR $4.38
- Resistance Level
- HOOK $5.23
- LNSR $4.67
- Average True Range (ATR)
- HOOK 0.31
- LNSR 0.30
- MACD
- HOOK 0.02
- LNSR 0.02
- Stochastic Oscillator
- HOOK 13.21
- LNSR 55.81
About HOOK HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.
About LNSR LENSAR Inc.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency and reproducibility by providing imaging, simplified procedure planning, efficient design and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. The consumable portion of the system consists of a disposable patient interface device, or PID, kit and a procedure license. Each procedure on each system requires the use of a PID kit.